¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

»ï¼º¼­¿ïº´¿ø 2023 Kore-Japan Joint Symposium on Gene therapy in Inborn Errors of Immunity : 2023-02-25

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
»ï¼º¼­¿ïº´¿ø 2023 Kore-Japan Joint Symposium on Gene therapy in Inborn Errors of Immunity : 2023-02-25
±³À°ÀÏÀÚ : 2023-02-25
±³À°Àå¼Ò : »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B2 Áß°­ÀÇÀå  
±³À°ÁÖÁ¦ : 2023 Kore-Japan Joint Symposium on Gene therapy in Inborn Errors of Immunity 
ÁÖÃÖ±â°ü : »ï¼º¼­¿ïº´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¼Ò¾Æû¼Ò³â°ú  
´ã´çÀÚ : ¼ÛÁöÇý
¿¬¶ôó : 02-2148-7316  
À̸ÞÀÏ : smcpidoffice@naver.com      
±³À°Á¾·ù : ÀÇ»çÇР     
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 02-25 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B2 Áß°­ÀÇÀå 09:50~10:00 Opening Remark  Yae-Jean Kim(Samsung Medical Center, Sungkyunkwan University, Korea) 
±âŸ 02-25 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B2 Áß°­ÀÇÀå 10:00~10:10 Introduction on gene therapy in Inborn Errors of Immunity  Yae-Jean Kim(Samsung Medical Center, Sungkyunkwan University, Korea) 
±³À°½Ã°£ 02-25 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B2 Áß°­ÀÇÀå 10:10~10:50 The first gene therapu in Japan: a long-term follow-up study of ADA (-) severe combined immunodeficiency paitens terated by retrovirs-stem cell gene therapy  Makoto Otsu(Kitasato University, Japan) 
È޽Ġ02-25 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B2 Áß°­ÀÇÀå 10:50~11:00 Break  () 
±³À°½Ã°£ 02-25 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B2 Áß°­ÀÇÀå 11:00~11:20 Genetic epidemiology of chronic granulomatous disease in Korea  Yae-Jean Kim(Samsung Medical Center, Sungkyunkwan University, Korea) 
±³À°½Ã°£ 02-25 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B2 Áß°­ÀÇÀå 11:20~12:00 Gene therapy for chronic granulomatous diseasa in Japan  Masafumi Onodera(National Center for child Health and Development, Japan) 
±³À°½Ã°£ 02-25 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B2 Áß°­ÀÇÀå 12:00~12:30 Retinal gene therapy : Current perspective  Sang Jin Kim(Samsung Medical Center, Sungkyunkwan University, Korea) 
½Ä»ç 02-25 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B2 Áß°­ÀÇÀå 12:30~13:30 Lunch time  () 
±³À°½Ã°£ 02-25 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B2 Áß°­ÀÇÀå 13:30~14:00 Gene therapy in Duchenne musular dystrophy and spinal muscualr atrophy  Jee Hun Lee(Samsung Medical Center, Sungkyunkwan University, Korea) 
±³À°½Ã°£ 02-25 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B2 Áß°­ÀÇÀå 14:00~14:30 Overview of the lentiviral vector system for ex-vivo gene therapy  Yeon-Soo Kim(Chugnam National University, Korea) 
±³À°½Ã°£ 02-25 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B2 Áß°­ÀÇÀå 14:30~15:10 Experience of gene therapy clinical trial for Wiskoot-Aldrich syundrome in Japan  Toru Uchiyama(National Center for child Health and Development, Japan) 
±³À°½Ã°£ 02-25 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B2 Áß°­ÀÇÀå 15:10~15:30 Development of gene therapy for Inborn Errors of Immunity using targeted genome editing  Toru Uchiyama(National Center for child Health and Development, Japan) 
È޽Ġ02-25 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B2 Áß°­ÀÇÀå 15:30~15:40 Break  () 
±³À°½Ã°£ 02-25 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B2 Áß°­ÀÇÀå 15:40~16:10 Gene therapeutics based on ribozy-mediated RNA replacement/editing strategy  Seong-Wook Lee(Dankook University, RZnomics, Korea) 
±³À°½Ã°£ 02-25 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B2 Áß°­ÀÇÀå 16:10~16:50 Safety and efficacy evaluation for gene therapy produxts  Masafumi Onodera(National Center for child Health and Development, Japan) 
±âŸ 02-25 »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø B2 Áß°­ÀÇÀå 16:50~17:50 Closing remark  Jee Hun Lee(Samsung Medical Center, Sungkyunkwan University, Korea) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" »ï¼º¼­¿ïº´¿ø 2023 Kore-Japan Joint Symposium on Gene therapy in Inborn Errors of Immunity : 2023-02-25""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û â¿øÇѸ¶À½º´¿ø â¿ø½Ã â¿øÀÇ»çȸ ȸ¿ø¿¬¼ö±³À° : 2023-02-25
´ÙÀ½±Û 2023 ³úÁ¹Áß Àç°³Åë ½ÉÆ÷Áö¾ö ¹× ´ëÇѳúÇ÷°ü³»Ä¡·áÀÇÇÐȸ Ãá°èº¸¼ö±³À° : 2023-02-25
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 51 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 45 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 46 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 54 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 40 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 84 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 32 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 46 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 41 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 48 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 53 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 35 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 39 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 45 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 47 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷